Status:
COMPLETED
Can Tailored Patient Letters Improve The Quality Of Diabetic Patient Care?
Lead Sponsor:
Scranton-Temple Residency Program
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if tailored letters sent to diabetic patients will improve care of diabetes.
Detailed Description
Diabetes care in the US is less than optimal. Some authors have found that targeted patient letters are also an effective tool to improve outcomes when they are part of a comprehensive disease managem...
Eligibility Criteria
Inclusion
- All active patients age 18 to 75 years with a diagnosis of diabetes mellitus were eligible.
- An active patient was defined as one having an ICD-9 code on the active problem list identifying the patient as diabetic, and a progress note in the EMR associated with an office visit within the prior 12 months.
Exclusion
- None
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
467 Patients enrolled
Trial Details
Trial ID
NCT00984841
Start Date
January 1 2009
End Date
July 1 2009
Last Update
September 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scranton-Temple Health Center
Scranton, Pennsylvania, United States, 18510